Erratum to: Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis


Vitamin D supplementation is recommended for women with osteoporosis. In the FOCUS-D trial comparing the combination tablet alendronate plus vitamin D3 5,600 IU (ALN/D) with standard care (SC) prescribed by patients’ personal physicians, ALN/D was more effective in improving serum 25(OH)D and bone turnover markers by 6 months and increasing spine and hip… (More)
DOI: 10.1007/s00223-013-9791-x


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.


Citations per Year

168 Citations

Semantic Scholar estimates that this publication has 168 citations based on the available data.

See our FAQ for additional information.